Anandita Agarwala
Overview
Explore the profile of Anandita Agarwala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Agarwala A, Deych E, Jones L, Sturm A, Aspry K, Ahmad Z, et al.
J Clin Lipidol
. 2022 Dec;
17(1):150-156.
PMID: 36470719
Background: Familial hypercholesterolemia (FH) is associated with an increased prevalence of premature atherosclerotic cardiovascular disease (ASCVD), however, little is known about sex-specific differences in premature ASCVD and its risk factors....
22.
Shah K, Patel J, Al Rifai M, Agarwala A, Bhatt A, Levitzky Y, et al.
Health Sci Rev (Oxf)
. 2022 Nov;
4.
PMID: 36438886
South Asians represent a growing percentage of the diverse population in the U.S. and are disproportionately impacted by a greater burden of aggressive and premature cardiovascular disease. There are multiple...
23.
Agarwala A, Petersen K, Jafari F, Kris-Etherton P
Prog Cardiovasc Dis
. 2022 Nov;
75:49-58.
PMID: 36410416
Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease and a healthy lifestyle is the first line of therapy for treatment. A healthy dietary pattern is a cornerstone for...
24.
Agarwala A, Ballantyne C, Stone N
JAMA Cardiol
. 2022 Nov;
8(1):96-97.
PMID: 36383356
No abstract available.
25.
Kirkpatrick C, Agarwala A, Maki K
J Clin Lipidol
. 2022 Nov;
16(6):769-775.
PMID: 36372716
No abstract available.
26.
Al Rifai M, Kianoush S, Jain V, Minhas A, Hussain A, Krittanawong C, et al.
Kans J Med
. 2022 Oct;
15:352-357.
PMID: 36196100
Introduction: Some groups of Asian Americans, especially Asian Indians, experience higher rates of atherosclerotic cardiovascular disease (ASCVD) compared with other groups in the U.S. Barriers in accessing medical care partly...
27.
Patel N, Kianoush S, Jia X, Nambi V, Koh S, Patel J, et al.
Kans J Med
. 2022 Aug;
15:267-272.
PMID: 36042841
Introduction: Adequate physical activity is an integral requirement for achieving cardiovascular health. Physical inactivity is the fourth leading cause of death worldwide. Hence, it is important to identify racial/ethnic groups...
28.
Quispe R, Sweeney T, Varma B, Agarwala A, Michos E
Curr Atheroscler Rep
. 2022 Jul;
24(10):767-778.
PMID: 35895246
Purpose Of Review: Mounting evidence continues to support the causal role of triglyceride-rich lipoproteins (TRL) in the development of atherosclerotic cardiovascular disease (ASCVD). Substantial residual ASCVD risk remains among high-risk...
29.
Cheeley M, Saseen J, Agarwala A, Ravilla S, Ciffone N, Jacobson T, et al.
J Clin Lipidol
. 2022 Jun;
16(4):361-375.
PMID: 35718660
Although statins are generally well tolerated, statin intolerance is reported in 5-30% of patients and contributes to reduced statin adherence and persistence, as well as higher risk for adverse cardiovascular...
30.
Poornima I, Indaram M, Ross J, Agarwala A, Wild R
J Clin Lipidol
. 2022 Mar;
16(3):253-260.
PMID: 35260347
Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. Preeclampsia (PreE) which includes hypertension and proteinuria during pregnancy, is thought to result...